AASLD News
People With Hepatitis C Who Actively Inject Illegal Drugs Have High Rates Of Hepatitis C Treatment Adherence And Cure
Preliminary data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that people who inject drugs who are infected with the hepatitis C virus have high rates of hepatitis C treatment adherence (completion of their treatment), and sustained virologic response. Based on these findings, researchers conclude these
NAFLD Patients Less Likely To Lose Weight, Need More Effective Weight Loss Strategies
Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that obese individuals with nonalcoholic fatty liver disease (NAFLD) were less likely to achieve a medically recommended five percent loss of body weight at three months on a very-low-calorie diet compared to obese counterparts without NAFLD.